Abstract:Introduction: Progressive osseous heteroplasia (POH) is a rare, debilitating disorder characterized by heterotopic ossification in the skin and muscles, resulting in contractures of the joints and progressive loss of function. While 60-70% of the POH patients have paternally inherited, inactivating pathogenic variants in GNAS, the remaining 30-40% have no known etiology. FAM111B pathogenic variants, located on chromosome 11q12.1, cause POIKTMP (hereditary fibrosing poikiloderma with tendon contractures, myopathy, and pulmonary fibrosis), a very rare, autosomal-dominant disorder with high frequency of de novo missense pathogenic variants, which affects multiple tissues and organs, causing extensive fibrosis and muscle adiposis, though the exact mechanism is unknown. To our knowledge, there are no reports of FAM111B associated with POH. We describe the first case of POH phenotype associated with a novel de novo frameshift pathogenic variant in the FAM111B and present an analysis of the protein structure and function caused by this genomic disruption. Case: A 15-year-old African-American male presented with generalized calcific nodules, progressive contractures, and muscle weakness leading to immobility, beginning at 6 years of age. Cutaneous examination showed generalized hard nodules varying from small to plaque-like ulcerated erupted skin lesions. Biochemical evaluation revealed 25(OH) vitamin D insufficiency (20 ng/mL), and normal levels of parathyroid hormone, FGF-23, alkaline phosphatase, calcium, and phosphorus. Skeletal survey radiographs and computed tomography (CT) of the chest, abdomen, and pelvis showed extensive soft tissue and muscle heterotopic ossifications involving shoulders, axillae, trunk, abdomen, pelvis, upper and lower extremities, in a clumped, conglomerate distribution within muscle, subcutaneous fat, and in some areas extending to the skin. There was no pulmonary fibrosis on the chest CT. The clinical and radiographic findings were most consistent with POH. A trio-clinical exome sequencing revealed a de novo heterozygous likely pathogenic variant in the FAM111B (OMIM # 615584) (c.1462delT [p.Cys488Valfs*21]). The resulted frameshift change in exon 4 replaced C-terminal region with 21 alternative amino acids. Multiple, previously reported disease-associated variants appear to localize within the trypsin-like cysteine/serine peptidase domain in which this variant occurs, supporting the functional significance of this region, though none have been previously reported to be associated with POH phenotype. Our 3D protein modeling showed obliteration of predicted protein folding and structure, and elimination of the zinc-binding domain, likely severely affecting protein function. Conclusion: This is the first case of POH phenotype associated with a novel de novo pathogenic frameshift variant in FAM111B. Whether the frameshift change in FAM111B predicts POH remains unclear. Further evaluations are necessary to fully elucidate this finding and the potential role and mechanism by which the FAM111B variants contributes to POH phenotype.

Progressive osseous heteroplasia in a Chinese infant and a novel mutation in the GNAS Gene.

Progressive Osseous Heteroplasia in a 5-Year-old Boy with a Novel Mutation in Exon 2 of GNAS: a Case Presentation and Literature Review

A novel GNAS mutation in pseudohypoparathyroidism type 1a with articular flexion deformity: A case report

The Phenotype and Genotype of Fibrodysplasia Ossificans Progressiva in China: a Report of 72 Cases.

Different AHO Phenotype in a Chinese Family with a Novel GNAS Missense Variant: a Case Report.

A novel mutation in the SLCO2A1 gene in a Chinese family with primary hypertrophic osteoarthropathy.

A Novel De Novo Frameshift Pathogenic Variant in the FAM111B Resulting in Progressive Osseous Heteroplasia Phenotype

NOVEL MUTATIONS IN THE WNT1, TMEM38B, P4HB, AND PLS3 GENES IN FOUR UNRELATED CHINESE FAMILIES WITH OSTEOGENESIS IMPERFECTA.

Identification of a Novel Mutation in Pseudohypoparathyroidism Type Ia in a Chinese Family

Identification of a novel GNAS mutation for pseudohypoparathyroidism in a Chinese family

Gnas Inactivation Alters Subcutaneous Tissues in Progression to Heterotopic Ossification

SOPH Syndrome with Growth Hormone Deficiency, Normal Bone Age, and Novel Compound Heterozygous Mutations in NBAS.

Two Novel Mutations in the SLCO2A1 Gene in a Chinese Patient with Primary Hypertrophic Osteoarthropathy.

Evaluating the Variety of GNAS Inactivation Disorders and Their Clinical Manifestations in 11 Chinese Children

Mise En Évidence De Deux Nouvelles Mutations Du Gène CLCN7 Par L’étude De Trois Familles Chinoises Atteintes D’une Ostéopétrose Autosomique Dominante De Type II

A novel nonsense mutation c.424G>T (p. G142X) in the first exon of XLas leading to osteopetrosis

Targeted Exome Sequencing Identified a Novel Mutation Hotspot and a Deletion in Chinese Primary Hypertrophic Osteoarthropathy Patients.

Characterization of Mineral and Bone Metabolism Biomarkers in a Chinese Consanguineous Twin Family with Primary Hypertrophic Osteoarthropathy.

Identification of Two Novel Mutations in the Slco2a1 Prostaglandin Transporter Gene in A Chinese Patient with Primary Hypertrophic Osteoarthropathy

A Novel Mutation and a Known Mutation in the CLCN7 Gene Associated with Relatively Stable Infantile Malignant Osteopetrosis in a Chinese Patient

Odontohypophosphatasia Caused by a Novel Combination of Two Heterozygous Variants: a Case Report